APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposomes Nanoparticle Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Liposomes Nanoparticle Drugs Industry Growth and Trends Forecast to 2032

20 December 2025124 pages

Choose your research edition.

Industry ResearchLiposomes Nanoparticle Drugs Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposomes Nanoparticle Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Liposomes Nanoparticle Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposomes Nanoparticle Drugs Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposomes Nanoparticle Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global Liposomes Nanoparticle Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Liposomes Nanoparticle Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Liposomes Nanoparticle Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liposomes Nanoparticle Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Liposomes Nanoparticle Drugs market include Takeda, Teva, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Chiesi Farmaceutici, Gilead Sciences, Zydus Cadila and TTY Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Liposomes Nanoparticle Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Liposomes Nanoparticle Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liposomes Nanoparticle Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liposomes Nanoparticle Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Liposomes Nanoparticle Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Liposomes Nanoparticle Drugs Market by Company

Takeda

Teva

Sun Pharmaceutical

Johnson & Johnson

Luye Pharma

Chiesi Farmaceutici

Gilead Sciences

Zydus Cadila

TTY Biopharma

Sayre Therapeutics

Pacira

Leadiant Biosciences

Kinyond

Jazz

Ipsen

Fudan-Zhangjiang

CSPC

Bausch Health

Alnylam

Acrotech Biopharma

Liposomes Nanoparticle Drugs Segment by Type

Liposomes Drugs

Lipid Nanoparticle Drugs

Liposomes Nanoparticle Drugs Segment by Application

Hospital

Retail Pharmacy

Other

Liposomes Nanoparticle Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposomes Nanoparticle Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposomes Nanoparticle Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposomes Nanoparticle Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Liposomes Nanoparticle Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Liposomes Nanoparticle Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Liposomes Nanoparticle Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Liposomes Nanoparticle Drugs Market Share by Region (2021-2026) Table 4. Global Liposomes Nanoparticle Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Liposomes Nanoparticle Drugs Market Share by Region (2027-2032) Table 6. Global Liposomes Nanoparticle Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Liposomes Nanoparticle Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Liposomes Nanoparticle Drugs Market Size Share by Type (2021-2026) Table 9. Global Liposomes Nanoparticle Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Liposomes Nanoparticle Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Liposomes Nanoparticle Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Liposomes Nanoparticle Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Liposomes Nanoparticle Drugs Market Size Share by Application (2021-2026) Table 24. Global Liposomes Nanoparticle Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Liposomes Nanoparticle Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Liposomes Nanoparticle Drugs Industry Trends Table 37. Liposomes Nanoparticle Drugs Industry Drivers Table 38. Liposomes Nanoparticle Drugs Industry Opportunities and Challenges Table 39. Liposomes Nanoparticle Drugs Industry Restraints Table 40. Global Liposomes Nanoparticle Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Liposomes Nanoparticle Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Liposomes Nanoparticle Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Liposomes Nanoparticle Drugs Key Company Headquarters & Area Served Table 44. Global Liposomes Nanoparticle Drugs Company, Product Type & Application Table 45. Global Liposomes Nanoparticle Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Liposomes Nanoparticle Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Liposomes Nanoparticle Drugs Product Portfolio Table 52. Takeda Recent Development Table 53. Teva Company Information Table 54. Teva Business Overview Table 55. Teva Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Liposomes Nanoparticle Drugs Product Portfolio Table 57. Teva Recent Development Table 58. Sun Pharmaceutical Company Information Table 59. Sun Pharmaceutical Business Overview Table 60. Sun Pharmaceutical Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sun Pharmaceutical Liposomes Nanoparticle Drugs Product Portfolio Table 62. Sun Pharmaceutical Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Liposomes Nanoparticle Drugs Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Luye Pharma Company Information Table 69. Luye Pharma Business Overview Table 70. Luye Pharma Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Luye Pharma Liposomes Nanoparticle Drugs Product Portfolio Table 72. Luye Pharma Recent Development Table 73. Chiesi Farmaceutici Company Information Table 74. Chiesi Farmaceutici Business Overview Table 75. Chiesi Farmaceutici Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Chiesi Farmaceutici Liposomes Nanoparticle Drugs Product Portfolio Table 77. Chiesi Farmaceutici Recent Development Table 78. Gilead Sciences Company Information Table 79. Gilead Sciences Business Overview Table 80. Gilead Sciences Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Gilead Sciences Liposomes Nanoparticle Drugs Product Portfolio Table 82. Gilead Sciences Recent Development Table 83. Zydus Cadila Company Information Table 84. Zydus Cadila Business Overview Table 85. Zydus Cadila Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Zydus Cadila Liposomes Nanoparticle Drugs Product Portfolio Table 87. Zydus Cadila Recent Development Table 88. TTY Biopharma Company Information Table 89. TTY Biopharma Business Overview Table 90. TTY Biopharma Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. TTY Biopharma Liposomes Nanoparticle Drugs Product Portfolio Table 92. TTY Biopharma Recent Development Table 93. Sayre Therapeutics Company Information Table 94. Sayre Therapeutics Business Overview Table 95. Sayre Therapeutics Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sayre Therapeutics Liposomes Nanoparticle Drugs Product Portfolio Table 97. Sayre Therapeutics Recent Development Table 98. Pacira Company Information Table 99. Pacira Business Overview Table 100. Pacira Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pacira Liposomes Nanoparticle Drugs Product Portfolio Table 102. Pacira Recent Development Table 103. Leadiant Biosciences Company Information Table 104. Leadiant Biosciences Business Overview Table 105. Leadiant Biosciences Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Leadiant Biosciences Liposomes Nanoparticle Drugs Product Portfolio Table 107. Leadiant Biosciences Recent Development Table 108. Kinyond Company Information Table 109. Kinyond Business Overview Table 110. Kinyond Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Kinyond Liposomes Nanoparticle Drugs Product Portfolio Table 112. Kinyond Recent Development Table 113. Jazz Company Information Table 114. Jazz Business Overview Table 115. Jazz Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Jazz Liposomes Nanoparticle Drugs Product Portfolio Table 117. Jazz Recent Development Table 118. Ipsen Company Information Table 119. Ipsen Business Overview Table 120. Ipsen Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Ipsen Liposomes Nanoparticle Drugs Product Portfolio Table 122. Ipsen Recent Development Table 123. Fudan-Zhangjiang Company Information Table 124. Fudan-Zhangjiang Business Overview Table 125. Fudan-Zhangjiang Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Fudan-Zhangjiang Liposomes Nanoparticle Drugs Product Portfolio Table 127. Fudan-Zhangjiang Recent Development Table 128. CSPC Company Information Table 129. CSPC Business Overview Table 130. CSPC Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. CSPC Liposomes Nanoparticle Drugs Product Portfolio Table 132. CSPC Recent Development Table 133. Bausch Health Company Information Table 134. Bausch Health Business Overview Table 135. Bausch Health Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Bausch Health Liposomes Nanoparticle Drugs Product Portfolio Table 137. Bausch Health Recent Development Table 138. Alnylam Company Information Table 139. Alnylam Business Overview Table 140. Alnylam Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Alnylam Liposomes Nanoparticle Drugs Product Portfolio Table 142. Alnylam Recent Development Table 143. Acrotech Biopharma Company Information Table 144. Acrotech Biopharma Business Overview Table 145. Acrotech Biopharma Liposomes Nanoparticle Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Acrotech Biopharma Liposomes Nanoparticle Drugs Product Portfolio Table 147. Acrotech Biopharma Recent Development Table 148. North America Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Liposomes Nanoparticle Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Liposomes Nanoparticle Drugs Market Share by Country (2021-2026) Table 151. North America Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Liposomes Nanoparticle Drugs Market Share Forecast by Country (2027-2032) Table 153. Europe Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Liposomes Nanoparticle Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Liposomes Nanoparticle Drugs Market Share by Country (2021-2026) Table 156. Europe Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Liposomes Nanoparticle Drugs Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Liposomes Nanoparticle Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Liposomes Nanoparticle Drugs Market Share by Country (2021-2026) Table 161. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Liposomes Nanoparticle Drugs Market Share Forecast by Country (2027-2032) Table 163. Latin America Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Liposomes Nanoparticle Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Liposomes Nanoparticle Drugs Market Share by Country (2021-2026) Table 166. Latin America Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Liposomes Nanoparticle Drugs Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Liposomes Nanoparticle Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Liposomes Nanoparticle Drugs Market Share by Country (2021-2026) Table 171. Middle East & Africa Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Liposomes Nanoparticle Drugs Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Liposomes Nanoparticle Drugs Product Image Figure 3. Global Liposomes Nanoparticle Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Liposomes Nanoparticle Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Liposomes Nanoparticle Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Liposomes Nanoparticle Drugs Market Share by Region (2021-2032) Figure 7. North America Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Liposomes Drugs Image Figure 13. Global Liposomes Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Lipid Nanoparticle Drugs Image Figure 15. Global Lipid Nanoparticle Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Liposomes Nanoparticle Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Liposomes Nanoparticle Drugs Market Share by Type 2025 VS 2032 Figure 18. North America Liposomes Nanoparticle Drugs Market Size Share by Type (2021-2032) Figure 19. Europe Liposomes Nanoparticle Drugs Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Share by Type (2021-2032) Figure 21. Latin America Liposomes Nanoparticle Drugs Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Liposomes Nanoparticle Drugs Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Liposomes Nanoparticle Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Liposomes Nanoparticle Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Liposomes Nanoparticle Drugs Market Size Share by Application (2021-2032) Figure 32. Europe Liposomes Nanoparticle Drugs Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Liposomes Nanoparticle Drugs Market Size Share by Application (2021-2032) Figure 34. Latin America Liposomes Nanoparticle Drugs Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Liposomes Nanoparticle Drugs Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Liposomes Nanoparticle Drugs Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Liposomes Nanoparticle Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Liposomes Nanoparticle Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Liposomes Nanoparticle Drugs Market Share by Country (2021-2032) Figure 41. Europe Liposomes Nanoparticle Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Liposomes Nanoparticle Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Liposomes Nanoparticle Drugs Market Share by Country (2021-2032) Figure 44. Asia-Pacific Liposomes Nanoparticle Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Liposomes Nanoparticle Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Liposomes Nanoparticle Drugs Market Share by Country (2021-2032) Figure 47. Latin America Liposomes Nanoparticle Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Liposomes Nanoparticle Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Liposomes Nanoparticle Drugs Market Share by Country (2021-2032) Figure 50. Middle East & Africa Liposomes Nanoparticle Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Liposomes Nanoparticle Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Liposomes Nanoparticle Drugs Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Liposomes Drugs
  • Lipid Nanoparticle Drugs
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Luye Pharma
  • Chiesi Farmaceutici
  • Gilead Sciences
  • Zydus Cadila
  • TTY Biopharma
  • Sayre Therapeutics
  • Pacira
  • Leadiant Biosciences
  • Kinyond
  • Jazz
  • Ipsen
  • Fudan-Zhangjiang
  • CSPC
  • Bausch Health
  • Alnylam
  • Acrotech Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Liposomes Nanoparticle Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Liposomes Nanoparticle Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Liposomes Nanoparticle Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Liposomes Nanoparticle Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Liposomes Nanoparticle Drugs Market Size (2021-2032)
  8. 1.5.1 North America Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Liposomes Nanoparticle Drugs Market Size Growth Rate (2021-2032)
2 Liposomes Nanoparticle Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Liposomes Drugs
  3. 2.1.2 Lipid Nanoparticle Drugs
  4. 2.2 Global Liposomes Nanoparticle Drugs Market Size by Type
  5. 2.2.1 Global Liposomes Nanoparticle Drugs Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Liposomes Nanoparticle Drugs Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Liposomes Nanoparticle Drugs Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Liposomes Nanoparticle Drugs Market Size by Regions
  9. 2.3.1 North America Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Liposomes Nanoparticle Drugs Market Size Breakdown by Type (2021-2026)
3 Liposomes Nanoparticle Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Liposomes Nanoparticle Drugs Market Size by Application
  6. 3.2.1 Global Liposomes Nanoparticle Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Liposomes Nanoparticle Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Liposomes Nanoparticle Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Liposomes Nanoparticle Drugs Market Size by Regions
  10. 3.3.1 North America Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Liposomes Nanoparticle Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Liposomes Nanoparticle Drugs Industry Trends
  2. 4.2 Liposomes Nanoparticle Drugs Industry Drivers
  3. 4.3 Liposomes Nanoparticle Drugs Industry Opportunities and Challenges
  4. 4.4 Liposomes Nanoparticle Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Liposomes Nanoparticle Drugs Revenue (2021-2026)
  2. 5.2 Global Liposomes Nanoparticle Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Liposomes Nanoparticle Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Liposomes Nanoparticle Drugs Company, Product Type & Application
  5. 5.5 Global Liposomes Nanoparticle Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Liposomes Nanoparticle Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Liposomes Nanoparticle Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Liposomes Nanoparticle Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Liposomes Nanoparticle Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Liposomes Nanoparticle Drugs Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharmaceutical
  14. 6.3.1 Sun Pharmaceutical Company Information
  15. 6.3.2 Sun Pharmaceutical Business Overview
  16. 6.3.3 Sun Pharmaceutical Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Liposomes Nanoparticle Drugs Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Liposomes Nanoparticle Drugs Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Luye Pharma
  26. 6.5.1 Luye Pharma Company Information
  27. 6.5.2 Luye Pharma Business Overview
  28. 6.5.3 Luye Pharma Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Luye Pharma Liposomes Nanoparticle Drugs Product Portfolio
  30. 6.5.5 Luye Pharma Recent Developments
  31. 6.6 Chiesi Farmaceutici
  32. 6.6.1 Chiesi Farmaceutici Company Information
  33. 6.6.2 Chiesi Farmaceutici Business Overview
  34. 6.6.3 Chiesi Farmaceutici Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Chiesi Farmaceutici Liposomes Nanoparticle Drugs Product Portfolio
  36. 6.6.5 Chiesi Farmaceutici Recent Developments
  37. 6.7 Gilead Sciences
  38. 6.7.1 Gilead Sciences Company Information
  39. 6.7.2 Gilead Sciences Business Overview
  40. 6.7.3 Gilead Sciences Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Gilead Sciences Liposomes Nanoparticle Drugs Product Portfolio
  42. 6.7.5 Gilead Sciences Recent Developments
  43. 6.8 Zydus Cadila
  44. 6.8.1 Zydus Cadila Company Information
  45. 6.8.2 Zydus Cadila Business Overview
  46. 6.8.3 Zydus Cadila Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Cadila Liposomes Nanoparticle Drugs Product Portfolio
  48. 6.8.5 Zydus Cadila Recent Developments
  49. 6.9 TTY Biopharma
  50. 6.9.1 TTY Biopharma Company Information
  51. 6.9.2 TTY Biopharma Business Overview
  52. 6.9.3 TTY Biopharma Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 TTY Biopharma Liposomes Nanoparticle Drugs Product Portfolio
  54. 6.9.5 TTY Biopharma Recent Developments
  55. 6.10 Sayre Therapeutics
  56. 6.10.1 Sayre Therapeutics Company Information
  57. 6.10.2 Sayre Therapeutics Business Overview
  58. 6.10.3 Sayre Therapeutics Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sayre Therapeutics Liposomes Nanoparticle Drugs Product Portfolio
  60. 6.10.5 Sayre Therapeutics Recent Developments
  61. 6.11 Pacira
  62. 6.11.1 Pacira Company Information
  63. 6.11.2 Pacira Business Overview
  64. 6.11.3 Pacira Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pacira Liposomes Nanoparticle Drugs Product Portfolio
  66. 6.11.5 Pacira Recent Developments
  67. 6.12 Leadiant Biosciences
  68. 6.12.1 Leadiant Biosciences Company Information
  69. 6.12.2 Leadiant Biosciences Business Overview
  70. 6.12.3 Leadiant Biosciences Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Leadiant Biosciences Liposomes Nanoparticle Drugs Product Portfolio
  72. 6.12.5 Leadiant Biosciences Recent Developments
  73. 6.13 Kinyond
  74. 6.13.1 Kinyond Company Information
  75. 6.13.2 Kinyond Business Overview
  76. 6.13.3 Kinyond Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Kinyond Liposomes Nanoparticle Drugs Product Portfolio
  78. 6.13.5 Kinyond Recent Developments
  79. 6.14 Jazz
  80. 6.14.1 Jazz Company Information
  81. 6.14.2 Jazz Business Overview
  82. 6.14.3 Jazz Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Jazz Liposomes Nanoparticle Drugs Product Portfolio
  84. 6.14.5 Jazz Recent Developments
  85. 6.15 Ipsen
  86. 6.15.1 Ipsen Company Information
  87. 6.15.2 Ipsen Business Overview
  88. 6.15.3 Ipsen Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Ipsen Liposomes Nanoparticle Drugs Product Portfolio
  90. 6.15.5 Ipsen Recent Developments
  91. 6.16 Fudan-Zhangjiang
  92. 6.16.1 Fudan-Zhangjiang Company Information
  93. 6.16.2 Fudan-Zhangjiang Business Overview
  94. 6.16.3 Fudan-Zhangjiang Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Fudan-Zhangjiang Liposomes Nanoparticle Drugs Product Portfolio
  96. 6.16.5 Fudan-Zhangjiang Recent Developments
  97. 6.17 CSPC
  98. 6.17.1 CSPC Company Information
  99. 6.17.2 CSPC Business Overview
  100. 6.17.3 CSPC Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 CSPC Liposomes Nanoparticle Drugs Product Portfolio
  102. 6.17.5 CSPC Recent Developments
  103. 6.18 Bausch Health
  104. 6.18.1 Bausch Health Company Information
  105. 6.18.2 Bausch Health Business Overview
  106. 6.18.3 Bausch Health Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Bausch Health Liposomes Nanoparticle Drugs Product Portfolio
  108. 6.18.5 Bausch Health Recent Developments
  109. 6.19 Alnylam
  110. 6.19.1 Alnylam Company Information
  111. 6.19.2 Alnylam Business Overview
  112. 6.19.3 Alnylam Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Alnylam Liposomes Nanoparticle Drugs Product Portfolio
  114. 6.19.5 Alnylam Recent Developments
  115. 6.20 Acrotech Biopharma
  116. 6.20.1 Acrotech Biopharma Company Information
  117. 6.20.2 Acrotech Biopharma Business Overview
  118. 6.20.3 Acrotech Biopharma Liposomes Nanoparticle Drugs Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Acrotech Biopharma Liposomes Nanoparticle Drugs Product Portfolio
  120. 6.20.5 Acrotech Biopharma Recent Developments
7 North America
  1. 7.1 North America Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Liposomes Nanoparticle Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Liposomes Nanoparticle Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Liposomes Nanoparticle Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Liposomes Nanoparticle Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Liposomes Nanoparticle Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Liposomes Nanoparticle Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Liposomes Nanoparticle Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst